Recent studies have found that HDAC1 is up-regulated in lung tissues of patients with PAH and model rats [11, 12]; selective class I HDAC inhibitors reverse monocrotaline (MCT) and hypoxia-induced pulmonary arterial remodeling and PAH by reducing HDAC1 expression [13]. The gene discussed is HDAC9; the disease is pulmonary arterial hypertension.